Xuan Beatty

Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo

F. Slack, A. Jackson, E. Anastasiadou, 2020, Clinical Cancer Research.

Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma

A. Jackson, M. Tetzlaff, A. Seto, 2018, British journal of haematology.

Preclinical Results Supporting Therapeutic Development of Mrg-106, an Oligonucleotide Inhibitor of Mir-155, in CTCL

A. Jackson, A. Seto, M. Warren, 2015 .